title: Rosiglitazone and pioglitazone in the treatment of diabetes mellitus.
authors.affiliation: Drug Information, Greenville Hospital System, Greenville, SC 29605, USA. JOdom@ghs.org
authors.forename: Jessica
authors.initials: J
authors.lastname: Odom
authors.forename: Bobbie
authors.initials: B
authors.lastname: Williamson
authors.forename: Lucy
authors.initials: L
authors.lastname: Carter
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D009203:Myocardial Infarction / Q000453:epidemiology / Q000209:etiology / Q000401:mortality; D047495:PPAR gamma / Q000819:agonists*; D000077205:Pioglitazone; D017410:Practice Guidelines as Topic; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D007004:Hypoglycemic Agents; D047495:PPAR gamma; D045162:Thiazolidinediones; D000077154:Rosiglitazone; D000077205:Pioglitazone